These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23631039)

  • 1. [Risks, contraindications, abuse and monitoring risks of testosterone replacement therapy (TRT)].
    Glina S; Wroclawski ER; Chaves OH
    Int Braz J Urol; 2006; 32 Suppl 1():31-4. PubMed ID: 23631039
    [No Abstract]   [Full Text] [Related]  

  • 2. Testosterone replacement in elderly men.
    Baum NH; Crespi CA
    Geriatrics; 2007 Sep; 62(9):15-8. PubMed ID: 17824721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Andropause (androgen deficiency of the aging male): diagnosis and management.
    Staerman F; Léon P
    Minerva Med; 2012 Oct; 103(5):333-42. PubMed ID: 23042368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of androgen disorder of aging male (ADAM)].
    Rhoden EL; Schiavini JL; Claro JA
    Int Braz J Urol; 2006; 32 Suppl 1():20-5. PubMed ID: 23631037
    [No Abstract]   [Full Text] [Related]  

  • 8. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
    Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
    Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.
    Elsherbiny A; Tricomi M; Bhatt D; Dandapantula HK
    Curr Cardiol Rep; 2017 Apr; 19(4):35. PubMed ID: 28361372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use.
    McBride JA; Coward RM
    Asian J Androl; 2016; 18(3):373-80. PubMed ID: 26908067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone: A Review for Orthopaedic Surgeons.
    Arcand MA; Poulin D; Testa EJ; Lemme NJ
    JBJS Rev; 2024 Jun; 12(6):. PubMed ID: 38889232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male hormone replacement therapy including "andropause".
    Tenover JL
    Endocrinol Metab Clin North Am; 1998 Dec; 27(4):969-87, x. PubMed ID: 9922917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andropause: is androgen replacement therapy indicated for the aging male?
    Hijazi RA; Cunningham GR
    Annu Rev Med; 2005; 56():117-37. PubMed ID: 15660505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer.
    Meza J; Weaver K; Martin S
    Am Fam Physician; 2013 Oct; 88(8):Online. PubMed ID: 24364582
    [No Abstract]   [Full Text] [Related]  

  • 16. Risks of testosterone-replacement therapy and recommendations for monitoring.
    Rhoden EL; Morgentaler A
    N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457
    [No Abstract]   [Full Text] [Related]  

  • 17. Risks of testosterone replacement.
    Redmond G
    N Engl J Med; 2004 May; 350(19):2004-6; author reply 2004-6. PubMed ID: 15131838
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment and management of male androgen disorders: an update.
    Chan I; Fui MN; Zajac JD; Grossmann M
    Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
    Maganty A; Osterberg EC; Ramasamy R
    Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of late-onset hypogonadism (andropause) treatment using three different formulations of injectable testosterone.
    Hohl A; Marques MO; Coral MH; Walz R
    Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):989-95. PubMed ID: 20126852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.